Document is current
Any future updates will be listed below
-
Authors
Aldewereld, Zachary http://orcid.org/0000-0003-4367-9036
Connolly, Brendan
Banks, Russell K.
Reeder, Ron
Holubkov, Richard
Berg, Robert A.
Wessel, David
Pollack, Murray M.
Meert, Kathleen
Hall, Mark
Newth, Christopher
Lin, John C.
Doctor, Allan
Cornell, Tim
Harrison, Rick E.
Zuppa, Athena F.
Dean, J. Michael
Carcillo, Joseph A.
-
Funding
Funding for this research was provided by:
National Institute of Child Health and Human Development (U10HD063108, U10HD049981, U10HD050096, U10HD050012, U01HD049934)
National Institute of General Medical Sciences (R01GM108618)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (5U01HD049934)
- License Information
-
More Information
Article History
Received: 20 February 2024
Accepted: 14 July 2024
First Online: 8 August 2024
Declarations
:
: Zachary Aldewereld and Brendan Connolly have no conflicts of interest. Drs Carcillo, Berg, Wessel, Pollack, Meert, Hall, Newth, Doctor, Cornell, Harrison, Zuppa, Reeder, Banks, Holubkov, and Dean received support for article research from the NIH. Dr. Carcillo’s institution also received funding from the National Institute of General Medical Sciences. Dr. Pollack disclosed that his research is supported by philanthropy from Mallinckrodt Pharmaceuticals. Dr. Hall received funding from LaJolla Pharmaceuticals (service as a consultant), unrelated to the current submission. Dr. Newth received funding from Philips Research North America. Dr. Doctor’s institution received funding from the Department of Defense and Kalocyte. Dr. Cornell disclosed he is co-founder of Pre-Dixon Bio. Dr. Holubkov received funding from Pfizer (Data Safety Monitoring Board [DSMB] member), Medimmune (DSMB member), Physicians Committee for Responsible Medicine (biostatistical consulting), DURECT Corporation (biostatistical consulting), Armaron Bio (DSMB past member), and St Jude Medical (DSMB past member). The remaining authors have disclosed that they do not have any potential conflicts of interest.
